- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration today approved Adcetris (brentuximab vedotin) to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy.
- Details
- Written by Yan Kennon
- Category: Health News
Jacksonville, Florida - National Brain Injury Awareness Month is a time to recognize the millions of Americans living with traumatic brain injury (TBI)-related disabilities.
- Details
- Written by Theresa Eisenman
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (multidrug resistant HIV, or MDR HIV).Trogarzo is administered intravenously once every 14 days by a trained medical professional and used in combination with other antiretroviral medications.
- Details
- Written by Hillary Hoffman
- Category: Health News
Washington, DC - A one-month antibiotic regimen to prevent active tuberculosis (TB) disease was at least as safe and effective as the standard nine-month therapy for people living with HIV, according to the results of a large international clinical trial. Adults and adolescents in the trial were more likely to complete the short-course regimen - consisting of daily doses of the antibiotics rifapentine and isoniazid for four weeks than the standard nine-month regimen of daily isoniazid.
- Details
- Written by Linda Huynh
- Category: Health News
Washington, DC - Tenofovir disoproxil fumarate (TDF), an antiviral drug commonly prescribed to treat hepatitis B infection, does not significantly reduce mother-to-child transmission of hepatitis B virus when taken during pregnancy and after delivery, according to a phase III clinical trial in Thailand funded by the National Institutes of Health. The study tested TDF therapy in addition to the standard preventative regimen - administration of hepatitis B vaccine and protective antibodies at birth - to explore the drug’s potential effects on mother-to-child transmission rates. The results appear in the New England Journal of Medicine.
- Details
- Written by National Heart, Lung, and Blood Institute
- Category: Health News
Washington, DC - Researchers have found that temporarily increasing the dosage of inhaled steroids when asthma symptoms begin to worsen does not effectively prevent severe flare-ups, and may be associated with slowing a child’s growth, challenging a common medical practice involving children with mild-to-moderate asthma.
Page 44 of 374
